Foresite Capital Opportunity Management V’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$9.67M Hold
5,227,307
29.04% 1
2022
Q2
$16M Hold
5,227,307
40.44% 1
2022
Q1
$37.7M Hold
5,227,307
52.85% 1
2021
Q4
$85.6M Buy
+5,227,307
New +$85.6M 57.37% 1